BIOARTIFICIAL ORGANS--SCIENCE, MEDICINE AND TECHNOLOGY

一个会议，“生物人工器官：科学，医学和技术 (Bio会议拟于一九九八年七月十八日至二十二日在 格林伍德酒店，班夫，阿尔伯塔，加拿大），探索当代和 新兴的生物人工器官的方法，因为它们与 不同领域 生物医学应用将得到重视。 的 目的是利用一个真正的跨学科的方法：化学， 物理化学、材料科学、高分子化学 表征，细胞培养，重组DNA技术，生物过程 工程和临床科学。 具体来说，它将带来 三组专业人士，他们通常不互动， 单一会议：（1）材料和聚合物科学家，（2） 生物工艺工程师和（3）医疗专业人员。 重点将 是这三个学科的交叉点。 主要覆盖面 将在胰腺、肝脏、皮肤、牙齿和骨骼区域。 的 该计划将强调科学基础， 并回顾每个区域的临床状况。将尝试 在聚合物之间具有大约25/25/50百分比的分配， 工程/生物医学类。 此外预计 参与者将来自学术界、工业界和临床 机构基本持平。 更具体而言是 会议的目的是：（1）促进 生物学家、医学专家和聚合物科学家， 新型生物相容性材料的设计和制备。(2)审查和 评估生物人工器官的发展和需求， 小组讨论。(3)福斯特国际，跨学科 合作研究。(4)提供资金让年轻人参与 科学-医学-技术相互作用中的科学家， 代表大会的特点。(5)为少数民族和妇女提供资金。 (6)在大会召开后10个月内出版一本编辑好的书， 包含会议记录（纽约科学院 科学）。 会议将具有戈登会议的风格。 的 工程基金会（纽约，NY）将承担主要 负责行政、后勤、机械、宣传、 住房和会议经费。 资金支持是 要求NIH、NSF、Whitaker Fdn.青少年糖尿病基金会，国家 科学与工程学院（加拿大），安大略材料中心 研究（加拿大），FNS（瑞士），欧洲联盟和来自各种 其他来源 会议记录将作为 一本同行评议的书

A conference, "Bioartificial Organs: Science, Medicine and Technology (Bio+AOII)", is proposed for July 18-22, 1998 (to be held in The Greenwood Inn, Banff, Alberta, Canada), to explore contemporary and emerging approaches to bioartificial organs as they interface with different fields. Biomedical applications will be highlighted. The intent is to make use of a truly interdisciplinary approach: chemistry, physical chemistry, materials science, polymer chemistry characterization, cell culture, recombinant DNA technology, bioprocess engineering, and clinical sciences. Specifically, it will bring together three groups of professionals, who do not normally interact at a single conference: (1) materials and polymer scientists, (2) bioprocess engineers, and (3) medical professionals. The emphasis will be at the cross-section of these three disciplines. The main coverage will be in the pancreas, liver, skin, dental and bone areas. The program will stress scientific fundamentals, evolve into applications and review the clinical status in each area. An attempt will be made to have approximately 25/25/50 percentage split amongst the polymer/ engineering/biological medical categories. In addition, it is expected that the participants will come from academia, industry and clinical institutions on approximately even basis. More specifically, the purpose of the conference is to: (1) Facilitate debate between biologists, medical professionals and polymer scientists regarding the design and preparation of novel biocompatible" materials. (2) Review and assessment of developments and needs for bioartificial organs through panel discussions. (3) Foster international, interdisciplinary collaborative research. (4) Provide the funding to involve young scientists in the science-medicine-technology interactions which characterize the congress. (5) Provide funding for minorities and women. (6) Publish an edited volume, within 10 months of the congress, containing the conference proceedings (The New York Academy of Sciences). The conference will have a Gordon Conference style. The Engineering Foundation (New York, NY) will assume primary responsibilities for administration, logistics, mechanics publicity, housing, and finances for the conference. The funding support is requested from NIH, NSF, Whitaker Fdn. Juvenile Diabetes Fdn., National Science and Engineering Fdn. (Canada), Ontario Center for Materials Research (Canada), FNS (Switzerland), European Union and from various other sources. The proceedings of the conference will be published as a peer reviewed volume.